SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Cardiovascular Pharmacology and Therapeutics
This Article
Right arrow Free Full Text (Free PDF) Free
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Harrington, L. S.
Right arrow Articles by Mitchell, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harrington, L. S.
Right arrow Articles by Mitchell, J. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Homeostatic Role of Toll-like Receptor 4 in the Endothelium and Heart

Louise S. Harrington, PhD

Cardiac, Vascular, and Inflammation Research, William Harvey Institute, Queen Mary's University of London, Charterhouse Square, London, EC1M 6BQ, l.harrington{at}imperial.ac.uk

Elizabeth Belcher, PhD

Cardiothoracic Pharmacology, Unit of Critical Care Medicine, National Heart and Lung Institute, Imperial College, Dovehouse Street, London, SW3 6LY

Laura Moreno, PhD

Cardiothoracic Pharmacology, Unit of Critical Care Medicine, National Heart and Lung Institute, Imperial College, Dovehouse Street, London, SW3 6LY

Martin J. Carrier, PhD

Cardiac, Vascular, and Inflammation Research, William Harvey Institute, Queen Mary's University of London, Charterhouse Square, London, EC1M 6BQ

Jane A. Mitchell, PhD

Cardiothoracic Pharmacology, Unit of Critical Care Medicine, National Heart and Lung Institute, Imperial College, Dovehouse Street, London, SW3 6LY, j.a.mitchell{at}imperial.ac.uk

Toll-like receptor 4 (TLR4) is a pattern recognition receptor for lipopolysaccharide from Gram negative bacteria and thus is integral to the innate immune response in mammals. In addition, TLR4 is associated with atherosclerosis in murine models. The current study shows that blood vessels from TLR4-/- mice have an intact endothelial layer and comparable expression of nitric oxide synthase 3 protein. However, endothelium-dependent dilation in response to acetylcholine in vessels from TLR4-/- mice is greatly reduced. By contrast, endothelium-independent smooth muscle dilation in response to sodium nitroprusside in vessels from TLR4-/- mice remains intact. Furthermore, this study shows that hearts from TLR4-/- mice display signs of left ventricular dilation. In contrast to results in vessels from TLR4-/- mice, endothelium-dependent responses to acetylcholine in vessels from TLR2-/- mice remain intact. These observations illustrate a novel role for TLR4 in the homeostatic control of a functional endothelium and, thereby, cardiovascular health.

Key Words: TLR4 • endothelium • dilation • hypertrophy • artery

Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 12, No. 4, 322-326 (2007)
DOI: 10.1177/1074248407306217


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement